STOCK TITAN
  1. Home
  2. AZRX

AZRX (AZRX) Stock Price, News & Analysis

AZRX

Company Description

This page collects what Stock Titan holds for AZRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
10.0M
Shares outstanding

Latest News

View All
+2.07%

AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today

+8.05%

AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma

acquisition
+652.16%

AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

acquisition
-14.75%

AzurRx BioPharma Announces Reverse Stock Split

stock split
-14.75%

AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

clinical trial covid-19
+2.01%

AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

clinical trial covid-19

AZRX has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, stock split, clinical trial, covid-19, conferences. View all AZRX news →

SEC Filings

View All

No SEC filings available for AZRX.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months